Clinical Trial Update: The "COSMOS"-Study (Copeptin in Osmoregulation and Stress Assessment)

View source ↗

Summary

The COSMOS study, conducted at University Hospital Basel, evaluated copeptin as a biomarker in osmoregulation and stress assessment in patients with stroke or t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke
• Transient Ischemic Attack

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Stroke, Transient Ischemic Attack | Status: COMPLETED